Raider, if I understand your post correctly, you present as being in the biotech business or knowing it very well; and have serious doubts/concerns about Novartis' true agenda in this deal and the level of care factor by IMU's directors.
So why is your sentiment a buy and you continue to hold? A bit inconsistent, one would think.
Furthermore, if IMU's product has the potential to upset the market equilibrium, then I as Novartis CEO, would definitely not bury the technology but wield it asap in order to weaken my competitors' market share. My Novartis shareholders would crucify me had I wasted a golden opportunity just to spite a junior biotech.
My suggested scenario happens all the time too. Look to all the mergers and acquisitions taking place around us. Or look to Roche/Tamiflu, or GSK/Relenza, etc.
We all want the best outcome for IMU. Right now, the hush-hush approach is testing our patience. It helps to reduce pessimism if we try to see both sides of the coin.
takeover?, page-12
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |